| Joseph Jay Schwartz, MD | |
|
229 Engle St, Englewood, NJ 07631-2409 | |
| (201) 567-8999 | |
| (201) 567-5385 |
| Full Name | Joseph Jay Schwartz |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 26 Years |
| Location | 229 Engle St, Englewood, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538185491 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Englewood Hospital And Medical Center | Englewood, NJ | Hospital |
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Valley Hospital | Ridgewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Endocrinology Consultants, Pc | 0840387023 | 8 |
News Archive
InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.
Findings released by the Health Department shed new light on the health effects of exposure to dust and debris among workers who responded to the World Trade Center disaster on September 11, 2001.
Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).
› Verified 5 days ago
| Entity Name | Endocrinology Consultants, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275721342 PECOS PAC ID: 0840387023 Enrollment ID: O20071105000379 |
News Archive
InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.
Findings released by the Health Department shed new light on the health effects of exposure to dust and debris among workers who responded to the World Trade Center disaster on September 11, 2001.
Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Jay Schwartz, MD 229 Engle St, Englewood, NJ 07631-2409 Ph: (201) 567-8999 | Joseph Jay Schwartz, MD 229 Engle St, Englewood, NJ 07631-2409 Ph: (201) 567-8999 |
News Archive
InDevR, developer of advanced life science products, announced that its ampliPHOX Colorimetric Detection Technology is being beta site-tested in anticipation of an upcoming product launch. The original intellectual property was licensed from the University of Colorado at Boulder.
Findings released by the Health Department shed new light on the health effects of exposure to dust and debris among workers who responded to the World Trade Center disaster on September 11, 2001.
Latest research by scientists at the University of Bath has shown why the anti-inflammatory drug ibuprofen might stop certain cancers from developing.
Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).
› Verified 5 days ago
Dr. Annalisa Pastore, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 60 Grand Ave, Englewood, NJ 07631 Phone: 201-308-5326 | |
Deborah A Fein, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Englewood, NJ 07631 Phone: 201-567-0446 | |
Jeffrey Martin Mitchel, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 370 Grand Ave, Englewood, NJ 07631 Phone: 201-567-7576 Fax: 201-567-8628 | |
Dennis Katechis, DO Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 177 N Dean St, Suite 100, Englewood, NJ 07631 Phone: 201-816-2508 Fax: 201-569-6111 | |
Dr. Ebben Will Smith, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 370 Grand Ave, Suite 102, Englewood, NJ 07631 Phone: 201-567-3370 | |
Dr. Ma. Conchitina Manas Fojas, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 229 Engle St, Englewood, NJ 07631 Phone: 201-567-5385 | |
Steven J Weisholtz, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 25 Rockwood Pl, Englewood, NJ 07631 Phone: 201-568-8130 Fax: 201-568-2450 |